We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Software Monitoring Helps Detect ICD Malfunctions

By HospiMedica International staff writers
Posted on 22 Mar 2012
A software-monitoring program that tracks implantable cardioverter-defibrillator (ICD) function could detect problems with the devices earlier than current monitoring processes, according to a new study.

Researchers at the Minneapolis Heart Institute Foundation (MN, USA) performed simulated prospective monthly full-cohort and propensity-matched comparative survival analyses on 3-center databases of the Sprint Fidelis--which was eventually recalled--and the Quattro Secure ICD, using a commercially available automated surveillance tool that was preset to detect early signals that an ICD was underperforming and trigger an alert if the log rank probability value was lower than 0.05. More...
Patients in both databases had their ICDs implanted between 2001 and 2008.

The results showed that the surveillance software simulated and detected problems with the recalled leads at least a year before recall; in all, 84 of 1,035 Fidelis (8.1%) and 23 of 1,675 Quattro (1.4%) leads failed, with the simulated full-cohort analysis triggering a sustained alert for Fidelis leads beginning 13 months after the first implant, and two years before Fidelis leads were actually removed from the market. In the propensity-matched analysis, the alert triggered 22 months after the first Fidelis implant and more than one year before the lead was recalled. The study was published ahead of print on March 6, 2012, in Circulation.

"The software works; looking at ICD patients implanted years ago, we showed that the automated program detects medical device problems faster than current approaches,” said lead author consulting cardiologist Robert Hauser, MD. “Pinpointing the malfunction a year earlier in this case could have spared thousands of patients the health risks, costs and inconvenience of receiving a device prone to failure.”

ICDs monitor heart rhythms and deliver electric shocks to restore normal rhythm when life-threatening, irregular heartbeats occur. However, the surgically implanted devices can malfunction, particularly in the leads that connect them to the heart, causing injury or death. ICD manufacturers track repeated malfunctions and issue recalls if they are widespread, but by the time of the recall, thousands of the devices have usually already been implanted in patients.

Related Links:

Minneapolis Heart Institute Foundation



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.